Net losses narrowed across the first nine months as the company rolled out new food-safety products and named President Jeff Kitchell its incoming chief executive.

June 17, 2026

EL CAJON, Calif. PURE Bioscience reported higher product sales for its fiscal third quarter and detailed a leadership change that will install a new chief executive this summer, while also narrowing its loss over the first nine months of the year.

The company makes a non-toxic antimicrobial called silver dihydrogen citrate, known as SDC, and trades on the OTCQB under the symbol PURE.

Quarterly Results

Net product sales reached $506,000 for the quarter ended April 30, up from $489,000 a year earlier. The company attributed the increase to wider sales across its distribution network.

Net loss for the quarter widened slightly to $624,000 from $580,000 in the same period last year. Excluding share-based compensation, the loss was $569,000 against $547,000. Loss per share held at one cent in both periods.

The nine-month picture was stronger. Product sales climbed to $1,656,000 from $1,435,000, a gain the company tied to higher demand across its end-user network. The year-to-date net loss narrowed to $1,873,000 from $2,067,000, helped by lower operating costs.

Cash and equivalents stood at $983,000 at quarter end, up from $334,000 at the close of the prior fiscal year. The company still carries a stockholders’ deficiency of about $5.8 million and an accumulated deficit of roughly $140.9 million. Current liabilities rose to $3,654,000, reflecting $2,754,000 in convertible notes payable to related parties that are now classified as current.

Leadership Transition

Robert Bartlett will retire as chief executive on July 31, the final day of the fiscal year. He will remain on the board and serve as an advisor to the CEO, and said he was proud of the team he had led. President Jeff Kitchell will take over as chief executive on August 1 and join the board.

Separately, board member Bernard Blotner is stepping down to focus on his health. Chairman Ivan Chen thanked him for helping guide the company’s strategic expansion.

Product and Market Momentum

Kitchell said sales have grown year over year while the company trimmed operating expenses. He pointed to newer offerings such as PURE Clean and to expansion into the dairy sector through a membrane treatment program run with distribution partners.

According to the company, recent progress spans several markets:

• Food brands: PURE Clean has begun gaining traction with national food brands since its launch, generating early sales.
• Food safety platform: The company is advancing automation systems, spiral freezer treatments, and drain sanitation programs, with several customer validations moving toward broader use.
• Transportation: PURE reported growth from trailer treatment programs and new industry partnerships, along with the introduction of PURE Fleet Wash, a product it describes as combining biodegradable ingredients with its SDC technology.

AJ Bogan, director of technical services, was scheduled to speak at the Membrane Technology Forum on June 16 about applying SDC to membrane treatment and performance.

Tim Steffensmeier, vice president of sales and marketing, said recent gains reflect deliberate steps by the team, and that the company is widening its reach and strengthening partnerships as it positions for long-term growth.

PURE develops antimicrobial products mainly for the food and beverage industry. Its platform is based on stabilized ionic silver, and the company positions SDC as a broad-spectrum agent that it says offers lower toxicity and a reduced risk of bacterial resistance compared with conventional treatment chemicals.